Overview

Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
To compare the pharmacokinetics of levetiracetam following single and multiple 15-minute intravenous infusions of 1500 mg levetiracetam between Japanese and Caucasian healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
UCB Japan Co. Ltd.
Treatments:
Etiracetam
Levetiracetam
Piracetam